In a 36-year-old woman with secondary amenorrhea for more than 2–3 months, intermittent spotting, low follicle‑stimulating hormone (FSH) and luteinizing hormone (LH) (~2–3 IU/L) and low estradiol (~73 pg/mL), what is the appropriate evaluation and management?

Evaluation and Management of Secondary Amenorrhea with Low Gonadotropins and Low Estradiol

This 36-year-old woman's hormonal profile—low FSH/LH (2-3 IU/L) and low estradiol (73 pg/mL)—is consistent with functional hypothalamic amenorrhea (FHA), but you must systematically exclude organic causes before making this diagnosis of exclusion. 1

Diagnostic Approach

Initial Laboratory Workup

Complete the following tests immediately 1:

• β-hCG (pregnancy test—mandatory first step)
• TSH and free T4 (hypothyroidism can mimic FHA; in FHA, these are typically low-normal)
• Prolactin (hyperprolactinemia >100 ng/mL requires further evaluation; in FHA, prolactin is low-normal)
• AMH (anti-Müllerian hormone) (helps assess ovarian reserve)
• Complete blood count, comprehensive metabolic panel, liver function tests (screen for chronic illness, malnutrition)
• Consider ESR/CRP if chronic inflammatory disease suspected 1

Interpreting the Hormonal Pattern

Your patient's pattern fits FHA 1:

• Low or low-normal LH (typically FSH > LH in FHA)
• Normal FSH concentrations
• Estradiol <50 pg/mL (your patient's 73 pg/mL is borderline low)
• This pattern distinguishes FHA from:
  • Primary ovarian insufficiency: Would show elevated FSH/LH with low estradiol (<20 pg/mL)
  • Organic hypogonadotropic hypogonadism: Would show very low/undetectable FSH and LH, requiring brain MRI to exclude pituitary/hypothalamic tumors 1

Critical History Elements

Specifically assess 1:

• Energy availability: Detailed dietary intake, caloric restriction, eating disorder symptoms (anorexia, bulimia)
• Exercise patterns: Hours per week, type, intensity (excessive exercise is a key trigger)
• Weight history: Recent weight loss, lowest adult weight, BMI trends
• Psychological stressors: Perfectionism, high achievement pressure, recent life stressors
• Athletic training: Competitive sports participation
• Medication use: Particularly psychotropics, opioids
• Fracture history: Indicates bone density concerns

Physical Examination Findings

Look for 1:

• Signs of hypoestrogenism: Thin, reddened vaginal mucosa; bradycardia; cool, mottled extremities
• Nutritional status: BMI, signs of malnutrition (hypercarotenemia, lanugo)
• Rule out hyperandrogenism: Hirsutism, acne, clitoromegaly (suggests PCOS overlap)
• Thyroid examination: Goiter
• Visual fields and fundoscopy: Rule out pituitary mass if FSH/LH are very low

When to Order Brain MRI

Order pituitary MRI if 1:

• FSH and LH are very low or undetectable (not just low-normal)
• Neurologic symptoms present (headaches, visual field defects)
• Hyperprolactinemia >100 ng/mL
• Other pituitary hormone deficiencies suspected

Your patient's FSH/LH of 2-3 IU/L likely does NOT require immediate MRI if other features support FHA and no neurologic symptoms exist.

Management Strategy

Non-Pharmacologic Treatment (First-Line)

Address underlying energy deficit 1:

1. Nutritional rehabilitation: Increase caloric intake to achieve positive energy balance; target BMI >18.5 kg/m²
2. Reduce excessive exercise: Decrease training volume/intensity by 10-20%
3. Psychological support: Cognitive behavioral therapy (CBT) for stress management, eating disorders, perfectionism 1
4. Multidisciplinary team: Dietitian, mental health professional, endocrinologist

This approach can restore menstruation in many patients within 3-6 months without medication.

Bone Health Assessment

Obtain DXA scan immediately 1:

• FHA patients are at high risk for low bone density due to hypoestrogenism
• Assess fracture risk
• Repeat annually if bone density is low

Hormonal Treatment Considerations

For bone protection and symptom management 1:

• Transdermal estradiol with cyclic progestin is preferred over oral contraceptives for bone health (though evidence is mixed)
• Oral contraceptives do NOT fully restore bone density but provide endometrial protection and contraception
• Hormone therapy is NOT a substitute for addressing underlying energy deficit

If Fertility Desired

Treatment hierarchy 1:

1. Pulsatile GnRH therapy (first-line but currently unavailable in the United States)

   • Most physiologic approach
   • Monofollicular development
   • Low multiple pregnancy risk (8.3%)
   • Pregnancy rate: 29% per cycle 1

2. Gonadotropin therapy (FSH + LH activity)

   • Use cautiously due to higher multiple pregnancy risk (14.8%)
   • Requires close monitoring
   • Women with FHA may need both FSH and LH activity for optimal response 1

3. Clomiphene citrate (trial only if sufficient endogenous estrogen)

   • Generally less effective in FHA
   • May consider prolonged protocol (10 days vs. standard 5 days) 1
   • Your patient's estradiol of 73 pg/mL suggests she might respond

Before fertility treatment, complete full fertility workup for both partners.

Common Pitfalls to Avoid

1. Don't assume infertility: Even with amenorrhea, sporadic ovulation can occur—counsel on contraception if pregnancy not desired 1

2. Don't miss organic causes: Always exclude pregnancy, thyroid disease, hyperprolactinemia, and primary ovarian insufficiency before diagnosing FHA

3. Don't rely on oral contraceptives alone: They mask the problem without addressing underlying energy deficit or fully protecting bone density

4. Don't overlook PCOS overlap: Up to 50% of FHA patients have polycystic ovarian morphology on ultrasound; elevated LH/FSH ratio may suggest this 2

5. Don't forget to reassess: If lifestyle modifications fail after 6 months, reconsider the diagnosis and evaluate for organic hypogonadotropic hypogonadism

Prognosis

Inform your patient 1:

• Menstrual recovery is possible with lifestyle modification
• Irregular menses during recovery are normal and don't require immediate re-evaluation
• Irregular cycles do not preclude conception
• Long-term hypoestrogenism increases cardiovascular and bone fracture risk